Literature DB >> 22943514

Determinants of pulmonary hypertension in young adults.

Maya Guglin1, Swathy Kolli, Ren Chen.   

Abstract

BACKGROUND: Risk factors of pulmonary hypertension (PH) are poorly understood. The objective of this study was to identify the determinants of PH in young adults.
METHODS: We analysed a limited access dataset from the CARDIA (Coronary Artery Risk Development in Young Adults) study provided by the National Heart, Lung and Blood Institute. Pulmonary arterial pressure was assessed by the Doppler pulmonary artery acceleration time (PAAT). Socio-demographic characteristics, self-reported clinical variables, echocardiographic variables, pulmonary function tests, systemic blood pressure and body mass index calculated from height and weight were used in multivariate analysis.
RESULTS: There were 4171 study subjects, mean age 24.9 ± 3.6 years, retained in year five with echocardiographic data available after five years of follow-up. The prevalence of severe PH (PAAT ≤ 70 ms) and mild to moderate PH (PAAT = 109.9-70.01 ms) was 1.1% and 14% respectively. Multivariate analysis revealed that body mass index (β = -1.09, p < 0.0001), female gender (β = 6.25, p < 0.0001), age (β = -0.30, p = 0.02), African American race (β = -2.57, p = 0.007), physical activity (β = 0.005, p = 0.002), current smoking (β = -3.42, p = 0.001), left atrial dimension (β = -2.97, p = 0.009) and diastolic dysfunction (β = -13.06, p = 0.006) were statistically significant variables predicting PH.
CONCLUSION: In this large, observational study of young adults, pulmonary hypertension, as assessed by echocardiography, is common. Diastolic dysfunction, obesity, physical inactivity and smoking are associated with elevated pulmonary arterial pressure in young adults.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22943514     DOI: 10.1111/ijcp.12008

Source DB:  PubMed          Journal:  Int J Clin Pract Suppl        ISSN: 1368-504X


  5 in total

1.  Bosentan or Macitentan Therapy in Chronic Thromboembolic Pulmonary Hypertension?

Authors:  M C J van Thor; L Ten Klooster; R J Snijder; J C Kelder; J J Mager; M C Post
Journal:  Lung       Date:  2019-10-03       Impact factor: 2.584

2.  Prevalence and clinical characteristics associated with pulmonary hypertension in African-Americans.

Authors:  Gaurav Choudhary; Matthew Jankowich; Wen-Chih Wu
Journal:  PLoS One       Date:  2013-12-16       Impact factor: 3.240

3.  Impaired right ventricular hemodynamics indicate preclinical pulmonary hypertension in patients with metabolic syndrome.

Authors:  Deepa M Gopal; Rajalakshmi Santhanakrishnan; Yi-Chih Wang; Nir Ayalon; Courtney Donohue; Youssef Rahban; Alejandro J Perez; Jill Downing; Chang-seng Liang; Noyan Gokce; Wilson S Colucci; Jennifer E Ho
Journal:  J Am Heart Assoc       Date:  2015-03-10       Impact factor: 5.501

4.  The Association of Body Mass Index With the Risk of Pulmonary Hypertension in Adults: A Systematic Review and Meta-Analysis of Observational Studies.

Authors:  Shoufang Pu; Lidan Yin; Bi Wen; Juan He
Journal:  Front Med (Lausanne)       Date:  2022-01-25

5.  Prevalence and determinants of pulmonary hypertension in a group of Cameroonian patients without chronic lung disease: a cross-sectional echocardiographic study.

Authors:  Ahmadou M Jingi; Jean Jacques Noubiap; Aurel T Tankeu; Liliane Mfeukeu-Kuate; Clovis Nkoke; Philippe Kamdem; Alain Patrick Menanga; Samuel Kingue
Journal:  BMC Res Notes       Date:  2017-11-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.